H-1B sponsorship profile: Lyell Immunopharma, Inc. Across U.S. Department of Labor LCA disclosures, Lyell Immunopharma, Inc filed 10 Labor Condition Applications covering 10 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (10 certified of 10 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Lyell Immunopharma, Inc’s H-1B petitions range from $144,000 at the low end to $277,778 at the high end, with a petition-weighted average of $187,511. That range reflects the mix of occupations the company sponsors, led by Sr. Director, Total Rewards (3 petitions at $250,352 avg), followed by Sr. Business Analyst, Financial Systems and Senior Scientist, Translational Pathology Laboratory. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Lyell Immunopharma, Inc is headquartered in South San Francisco, CA under NAICS code 3254, and places H-1B workers across 2 states, most heavily in CA, WA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Lyell Immunopharma, Inc ranks. By H-1B petition volume, Lyell Immunopharma, Inc is #16,610 of 119,880 employers nationally and #2,625 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.